Neuroendocrine control of thymic hormonal production. II. Stimulatory effects of endogenous opioids on thymulin production by cultured human and murine thymic epithelial cells.
Data have now accumulated to strongly demonstrate that several neuropeptides, including endogenous opioids, can have immunomodulatory functions. Most of the studies have so far focused on the direct action of these substances on lymphocytes. We decided to investigate whether thymic epithelial cells (TEC) - the major component of the thymic microenvironment - could also be modulated by endogenous opioids. Primary cultures of human and murine TEC were subjected to several opioids (alpha-beta- or gamma-endorphins, as well as met- or leuenkephalins) applied in concentrations ranging from 10(-6) to 10(-9) M. On the following days we measured the levels of thymulin (a chemically-defined thymic hormone known to stimulate some steps of T-cell differentiation) in the culture supernatants, as well as the numbers of thymulin containing cells, evaluated by immunofluorescence with an anti-thymulin monoclonal antibody. After treatment of TEC cultures with beta-endorphin or leu-enkephalin a significant increase in the levels of thymulin in the culture media was observed, paralleled by a rise in the percentage of thymulin containing cells. In addition, this stimulatory effect was dose-dependent. Preincubation of the opioids with the specific antibodies abrogated the opioid-induced stimulatory effect on TEC. Moreover, naloxone, an opioid receptor antagonist, blocked the effect of beta-endorphin on thymulin production, suggesting that the effect of this neuropeptide on epithelial cells was mediated by an opioid receptor. Importantly, no effect on thymulin production was observed with the other opioids used, whatever the dose. These results suggest that, at least in vitro, beta-endorphin and leu-enkephalin stimulate the hormonal function of the thymic epithelium. These findings lead to the general concept that the modulatory role of endogenous opioids on the immune system is not restricted to lymphocytes but can also take place at the level of cells belonging to T-cell differentiating microenvironments.
Oswaldo Cruz Institute, Rio de Janeiro, Brésil, France.
W
W
Savino
M C
MC
Gagnerault
J F
JF
Bach
M
M
Dardenne
D000818:Animals; D000911:Antibodies, Monoclonal; D002478:Cells, Cultured; D004723:Endorphins / Q000502:physiology*; D004743:Enkephalin, Leucine / Q000502:physiology; D004744:Enkephalin, Methionine / Q000502:physiology; D004848:Epithelium / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D013935:Thymic Factor, Circulating / Q000096:biosynthesis*; D013950:Thymus Gland / Q000378:metabolism*; D013951:Thymus Hormones / Q000096:biosynthesis*
D000911:Antibodies, Monoclonal; D004723:Endorphins; D013951:Thymus Hormones; D009270:Naloxone; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; D013935:Thymic Factor, Circulating